Changes in B and T-cell subsets and NMO-IgG/AQP-4 levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica
Background: There is increasing evidence supporting that neuromyelitis optica (NMO) is an inflammatory humoral mediated disorder associated with NMO-IgG/AQP-4 antibodies. However, little is known about the subsets of B cells and T cells that contribute to the pathogenesis or therapy response. Object...
Main Authors: | C. de Andrés, R. Teijeiro, A. Saiz, P. Fernández, S. Sánchez-Ramón |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2015-06-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580815000589 |
Similar Items
-
NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
by: Brian G. Weinshenker, et al.
Published: (2006-01-01) -
Detection and clinical value of NMO-IgG in neuromyelitis optica
by: De-hui HUANG, et al.
Published: (2014-09-01) -
Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India
by: Manish Mittal, et al.
Published: (2014-07-01) -
Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
by: Tarso Adoni, et al.
Published: (2008-06-01) -
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
by: Mohammad Hossein Harirchian, et al.
Published: (2015-02-01)